Dr. Gretchen Felton, MD MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4627 Chatelain Terrace, Golden Valley, MN 55422 Phone: 763-377-9217 |
Fern Rubin, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5851 Duluth St, 317, Golden Valley, MN 55422 Phone: 763-546-4301 |
Laura Mccarthy, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8401 Golden Valley Rd, Golden Valley, MN 55427 Phone: 952-993-8300 Fax: 952-993-8331 |
Dr. Karen A. Dahlgren, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8815 Elgin Pl N, Golden Valley, MN 55427 Phone: 763-545-7431 |
News Archive
In an opinion piece published on contextChina, Robert O'Brien, a PhD candidate in international relations at the University of Oxford, examines how China's new first lady, acclaimed folk singer Peng Liyuan, might influence public health activism in the country.
With the increasing number of infections across the globe, scientists have resorted to studying existing drugs in the hope of discovering a cure for the coronavirus disease (COVID-19). A team of researchers has found that an existing drug, Nafamostat or Fusan, a drug used to treat acute pancreatitis, may effectively block the process used by the novel coronavirus to spread and cause illness.
University of Vermont Professor of Neurology and migraine expert Robert Shapiro, M.D., Ph.D., says U.S. Representative and presidential candidate Michele Bachmann's public disclosure of her migraine condition has brought much-needed awareness to this disabling, often-stigmatized disorder, which afflicts millions of Americans.
Researchers with the Department of Veterans Affairs (VA) and the University of California at Los Angeles (UCLA) found that a diet high in docosahexenoic acid, or DHA-an omega-3 fatty acid found in relatively high concentrations in cold-water fish-dramatically slowed the progression of Alzheimer's disease in mice.
Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation System to treat obstructive sleep apnea.
› Verified 2 days ago